Lymph node dissection in differentiated thyroid cancer: review of modern tendencies

Main Article Content

V.A. Smoliar
О.А. Tovkay
V.О. Palamarchuk
V.G. Khoperiya


Recently, there has been a significant increase in the incidence of thyroid cancer (TC), both due to the adverse environmental effects and the rapid development of imaging methods. This led to the search for adapted and less aggressive therapeutic protocols, avoiding the risk of complications and inadequate interventions. Despite the predominantly favorable prognosis for differentiated thyroid cancer (DTC), the presence of metastases to the lymph nodes is associated with an increased risk of relapse, which significantly deteriorates the quality of life and adversely affects the prognosis of the disease. Currently, TC treatment is being carried out in general surgical hospitals, which is accompanied by a large number of inadequately executed surgical procedures and a high frequency of postoperative complications. In addition, in our country, radioiodine therapy remains unavailable to most patients, and there is no registry of this pathology to assess the effectiveness of treatment. Taking into account the latest guidelines of endocrine societies, we analyzed the main approaches to determining the indications and volume of lymph node dissection for DTC in terms of their benefits and risks. The literature data showed that the discussion is still open, and surgeons are divided between supporters and opponents of its use. That is why there is a need for additional clinical and perspective long-term randomized studies of prognostically significant factors when choosing approaches to lymph node dissection in DTC.

Article Details

How to Cite
Smoliar, V., Tovkay О., V. Palamarchuk, and V. Khoperiya. “Lymph Node Dissection in Differentiated Thyroid Cancer: Review of Modern Tendencies”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 8, Dec. 2018, pp. 749-55, doi:10.22141/2224-0721.14.8.2018.154855.
Endocrine Surgery


Agate L, Lorusso L, Elisei R. New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. J Endocrinol Invest. 2012;35(6 Suppl):3-9.

Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006 May 10;295(18):2164-7. doi: 10.1001/jama.295.18.2164.

Wang Y, Wang W. Increasing Incidence of Thyroid Cancer in Shanghai, China, 1983–2007. Asia Pac J Public Health. 2015 Mar;27(2):NP223-9. doi: 10.1177/1010539512436874.

Bellevicine C, Vigliar E, Malapelle U, et al. Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases. Cytopathology. 2016 Apr;27(2):115-21. doi: 10.1111/cyt.12243.

Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212. doi: 10.1155/2013/965212.

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.

Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8.

Shah MD, Hall FT, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope. 2003 Dec;113(12):2102-7. doi: 10.1097/00005537-200312000-00008.

Wang TS, Dubner S, Sznyter LA, Heller KS. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):110-3. doi: 10.1001/archotol.130.1.110.

Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid. 1999 May;9(5):421-7. doi: 10.1089/thy.1999.9.421.

Bhargav PRK, Mishra A, Agarwal G, et al. Long term outcome of differentiated thyroid carcinoma: experience in a developing country. World J Surg. 2010 Jan;34(1):40-7. doi: 10.1007/s00268-009-0293-y.

Cooper DS, Specker B, Ho M, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid. 1998 Sep;8(9):737-44. doi: 10.1089/thy.1998.8.737.

Lin JD, Chao TC, Huang MJ, Weng HF, Tzen KY. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation. Am J Clin Oncol. 1998 Feb;21(1):77-81.

Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O’Sullivan B. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer. 1997 Jun 15;79(12):2414-23.

Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002 Aug;26(8):879-85. doi: 10.1007/s00268-002-6612-1.

Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998 Sep;228(3):320-30.

Loyo M, Tufano RP, Gourin CG. National trends in thyroid surgery and the effect of volume on short-term outcomes. Laryngoscope. 2013 Aug;123(8):2056-63. doi: 10.1002/lary.23923.

Gourin CG, Tufano RP, Forastiere AA, Koch WM, Pawlik TM, Bristow RE. Volume-based trends in thyroid surgery. Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1191-8. doi: 10.1001/archoto.2010.212.

Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery. 2007 Dec;142(6):887-99; discussion 887-99. doi: 10.1016/j.surg.2007.09.003.

Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fineneedle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2004 Jan;60(1):21-8.

Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer. 2003 Jul 1;98(1):31-40. doi: 10.1002/cncr.11442.

Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am. 1996 Jan;5(1):43-63.

Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994 Jul-Aug;18(4):559-67; discussion 567-8.

Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003 Apr;13(4):381-7. doi: 10.1089/105072503321669875.

Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992 Dec;112(6):1139-46; discussion 1146-7.

Qubain SW, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002 Mar;131(3):249-56.

Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab. 1997 May;82(5):1638-41. doi: 10.1210/jcem.82.5.4062.

Solorzano CC, Carneiro DM, Ramirez M, Lee TM, Irvin GL. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg. 2004 Jul;70(7):576-80; discussion 580-2.

Shimamoto K, Satake H, Sawaki A, Ishigaki T, Funahashi H, Imai T. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol. 1998 Nov;29(1):4-10.

Stulak JM, Grant CS, Farley DR, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg. 2006 May;141(5):489-94; discussion 494-6. doi: 10.1001/archsurg.141.5.489.

Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003 Dec;134(6):946-54; discussion 954-5. doi: 10.1016/S0039.